The U.S. Court of Appeals for the Fifth Circuit granted the Federal Drug Administration a partial stay in a late Wednesday night, unpublished opinion affecting the nationwide removal of an abortion pill from the market.

By a 2-1 vote, a three-judge panel permitted other aspects of a federal district court judge’s ruling to take effect that would block a seven-year effort by the FDA to widen access to the drug.